Publication

Increased 3-O-sulfated heparan sulfate in Alzheimer's disease brain is associated with genetic risk gene HS3ST1

Downloadable Content

Persistent URL
Last modified
  • 06/25/2025
Type of Material
Authors
    Zhangjie Wang, UNC Eshelman School of PharmacyVaishail N Patel, National Institute of Dental and Craniofacial Research (NIDCR)Xuehong Song, Byrd Alzheimer’s Center and Research InstituteYongmei Xu, UNC Eshelman School of PharmacyAndrea M Kaminski, National Institute of Environmental Health Sciences (NIEHS)Vivien Uyen Doan, UNC Eshelman School of PharmacyGuowei Su, GLYCAN THERAPEUTICS, LLCYien Liao, UNC Eshelman School of PharmacyDylan Mah, Center for Biotechnology & Interdisciplinary StudiesFuming Zhang, Center for Biotechnology & Interdisciplinary StudiesVijayakanth Pagadala, GLYCAN THERAPEUTICS, LLCChunyu Wang, Center for Biotechnology & Interdisciplinary StudiesLars C Pedersen, National Institute of Environmental Health Sciences (NIEHS)Lianchun Wang, Byrd Alzheimer’s Center and Research InstituteMatthew P Hoffman, National Institute of Dental and Craniofacial Research (NIDCR)Marla Gearing, Emory UniversityJian Liu, UNC Eshelman School of Pharmacy
Language
  • English
Date
  • 2023-05-26
Publisher
  • American Association for the Advancement of Science
Publication Version
Copyright Statement
  • © 2023 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 9
Issue
  • 21
Start Page
  • eadf6232
End Page
  • eadf6232
Grant/Funding Information
  • J.L. lab at UNC has received a gift from Glycan Therapeutics to support research in glycosciences.
Supplemental Material (URL)
Abstract
  • HS3ST1 is a genetic risk gene associated with Alzheimer's disease (AD) and overexpressed in patients, but how it contributes to the disease progression is unknown.We report the analysis of brain heparan sulfate (HS) from AD and other tauopathies using a LC-MS/MS method. A specific 3-O-sulfated HS displayed sevenfold increase in the AD group (n = 14, P < 0.0005). Analysis of the HS modified by recombinant sulfotransferases and HS from genetic knockout mice revealed that the specific 3-O-sulfated HS is made by 3-O-sulfotransferase isoform 1 (3-OST-1), which is encoded by the HS3ST1 gene. A synthetic tetradecasaccharide (14-mer) carrying the specific 3-O-sulfated domain displayed stronger inhibition for tau internalization than a 14-mer without the domain, suggesting that the 3-O-sulfated HS is used in tau cellular uptake. Our findings suggest that the overexpression of HS3ST1 gene may enhance the spread of tau pathology, uncovering a previously unidentified therapeutic target for AD.
Author Notes
Keywords
Research Categories
  • Health Sciences, Pharmacology

Tools

Relations

In Collection:

Items